Glucose-induced sympathetic activity and energy expenditure during acute α2-adrenergic antagonism in obese subjects

International Journal of Obesity

Volumn 24, Issue 6, 2000, Pages 695-700

  Thalamas, C ^a,b   Galitzky, J ^a   Senard J M ^a   Lafontan, M ^a   Montastruc, J L ^a   Berlan, M ^a   Barbe, P ^a  

^a INSERM   (France)

^b Centre d'Investigation Clinique   (France)

Author keywords

Diet induced thermogenesis; Facultative thermogenesis; Sympathetic nervous system

Indexed keywords

ADRENALIN; ALPHA 2 ADRENERGIC RECEPTOR; FATTY ACID; GLYCEROL; IDAZOXAN; INSULIN; NORADRENALIN;

ADRENALIN BLOOD LEVEL; ADRENERGIC SYSTEM; ADULT; ARTICLE; BLOOD PRESSURE; CALORIMETRY; CARBON DIOXIDE EXCRETION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENERGY EXPENDITURE; FATTY ACID BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; GLYCEROL BLOOD LEVEL; HEART RATE; HUMAN; INSULIN BLOOD LEVEL; MALE; NERVE CONDUCTION; NORADRENALIN BLOOD LEVEL; OBESITY; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THERMOGENESIS;

EID: 0034076635     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0801221     Document Type: Article

References (31)

1. 2-antagonists and lipid mobilizing strategies. Am J Clin Nutr 1992; 55: 219S-227S
2. 2 Goldberg MR, Hollister AS, Robertson D. Influences of yohimbine on blood pressure, autonomic reflexes, and plasma catecholamines in humans. Hypertension 1983; 5: 772-778.
3. 3 Zahorska-Markiewicz B, Kucio C, Piscoriska D. Adrenergic control of lipolysis and metabolic responses in obesity. Horm Metab Res 1986; 18: 693-697.
4. 4 Berlan M, Galitzky J, Riviére D, Foureau M, Tran M-A, Flores R, Louvet J-P, Houin G, Lafontan M. Plasma catecholamine level and lipid mobilization induced by yohimbine in obese and non-obese women. Int J Obes 1991; 15: 305-315.
5. 5 Jéquier E. The influences of nutrient administration on energy expenditure in man. Clin Nutr 1986; 5: 181-186.
6. 6 Welle S, Lilavivathana U, Campbell R. Increased plasma noripinephirine concentrations and metabolic rates following glucose ingestion in man. Metabolism 1980; 29: 806-809.
7. 7 Acheson K, Jéquier E, Wahren J. Influence of β-adrenergic blockade on glucose induced thermogenesis in man. J Clin Invest 1983; 72: 981-809.
8. 8 Acheson KJ, Ravussin E, Wahren J, Jéquier E. Thermic effect of glucose in man. Obligatory and facultative thermogenesis. J Clin Invest 1984; 74: 1077-1083.
9. 9 Berne C, Fagius J, Niklasson F. Sympathetic response to oral carbohydrate administration. Evidence from microelectrode nerve recording. J Clin Invest 1989; 84: 1403-1409.
10. 10 Muller-Hess R, Geser C, Pittet P, Chappuis P, Jéquier E, Felber JP. Interaction of insulin and epinerphrine in human metabolism: their influence on carbohydrate and lipid oxidation rate. Diabete Métab 1975; 1: 151-157.
11. 11 Golay A, Schutz Y, Meyer D. Glucose-induced thermogenesis in nondiabetic and diabetic obese subjects. diabetes 1982; 11: 1023-1028.
12. 12 Bessard T, Schutz Y, Meyer D. Glucose-induced thermogenesis in nondiabetic and diabetic obese subjects. AM J Clin Nutr 1983; 38: 680-693.
13. 13 Schutz Y, Golay A, Felber J, Jéquier E. Decreased glucose-induced thermogenesis after weight loss in obese subject: a predisposition factor for relapse for obesity. AM J Clin nutr 1984; 39: 380-387.
14. 14 Laville M, Cornu C, Normand S, Mithieux G, Beylot M, Riou JP. Decreased glucose-induced thermogenesis at the onset of obesity. AM J Clin nutr 1993; 57: 851-856.
15. 2-antagonist. J Hyperten 1983; 1: 109-111.
16. 16 Ferrannini E. The theoretical bases of indirect calorimetry: a review. Metabolism 1988; 37: 287-301.
17. 17 Hunt LM. An analytic formula to instantaneously determine total metabolic rate. J Appl Physiol 1969; 27: 731-733.
18. 18 Bradley DC, Kaslow HR. Radiometric assays for glycerol, glucose and glycogen. Anal Biochem 1989; 180: 11-16.
19. 19 O'Dea K, Esler M, Leonard P, Stockigt JR, Nestel P. Noradrenaline turnover during under-and overeating in normal weight subjects. Metabolism 1982; 31: 896-899.
20. 20 Schwartz RS, Halter JB, Bierman EL. Reduced thermic effect of feeding in obesity: role of norepinephirine. Metabolism 1983; 32: 114-117.
21. 21 Fagius J, Berne C. Increase in muscle nerve sympathetic activity in humans after food intake. Clin Sci 1994; 86: 159-167.
22. 22 Spraul M, Ravussin E, Fontvieille A, Rising R, Larson D, Anderson E. Reduced sympathetic nervous activity. A potential mechanism predisposing to body weight gain. J Clin Invest 1993; 92: 1730-1735.
23. 23 Golay A, Schutz Y, Felber JP. Lack of thermogenic response to glucose/insulin infusion in diabetic obese subjects. Int J Obes 1986; 10: 107-116.
24. 24 Gumbiner B, Thorburn AW, Henry RR. Reduced glucose-induced thermogenesis is present in noninsulin-dependent diabetes mellitus without obesity. J Clin Endorcrinol Metab 1991; 72: 801-807.
25. 25 Ruffolo RRJ, Hieble JP. a-Adrenoceptors. Pharmac of Ther 1994; 61: 1-64.
26. 2-adrenoceptors: the regulation and fat cell function and lipolysis. Endoc and Rev 1995; 16: 716-738.
27. 27 Galitzky J, Vermorel M, Lafontan M, Montastruc O, Berlan M. Thermogenic and lipolytic effect of yohinbine in the dog. Br J Pharmac 1991; 104: 514-518.
28. 28 Jung RT, Shetty PS, James WPT, Barrand MA, Callingham BA. Reduced thermogenesis in obesity. Nature 1979; 279: 322-323.
29. 29 Spraul M, Ravussin E, Fontvieille AM, Rising R, Larson DE, Anderson EA. Reduced sympathetic nervous activity. A potential mechanism predisposing to body weight gain. J Clin Invest 1993; 92: 1730-1735.
30. 30 Wang X, Rondu F, Lamouri A. Effect of S-21663 (PMS), an imidazoline derivative on glucose tolerance and insulin secretion in a rat model of type II diabetes J Pharmac Exp Ther 1995; 278: 82-89.
31. 31 Pele-Tounian A, Wang X, Rondu F, Lamouri A, Touboul E, Marc S, Dokhan R, Pfeiffer B, Manechez D, Renard P, Guardolia-Lemaître B, Godfroid J, Pénicaud L, Ktorza A. Potent antihyperglycaemic property of a new imidazoline derivative S-22068 (PMS 847) in a rat model of NIDDM. Br J Pharmac 1998; 124: 1591-1596.